[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.
 
 
Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Article Types

Countries / Regions

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Search Results (332)

Search Parameters:
Keywords = GPS-free

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
26 pages, 6434 KiB  
Article
Motion and Inertia Estimation for Non-Cooperative Space Objects During Long-Term Occlusion Based on UKF-GP
by Rabiul Hasan Kabir and Xiaoli Bai
Sensors 2025, 25(3), 647; https://doi.org/10.3390/s25030647 - 22 Jan 2025
Viewed by 370
Abstract
This study addresses the motion and inertia parameter estimation problem of a torque-free, tumbling, non-cooperative space object (target) under long-term occlusions. To solve this problem, we employ a data-driven Gaussian process (GP) to simulate sensor measurements. In particular, we implement the multi-output GP [...] Read more.
This study addresses the motion and inertia parameter estimation problem of a torque-free, tumbling, non-cooperative space object (target) under long-term occlusions. To solve this problem, we employ a data-driven Gaussian process (GP) to simulate sensor measurements. In particular, we implement the multi-output GP to predict the projection measurements of a stereo-camera system onboard a chaser spacecraft. A product kernel, consisting of two periodic kernels, is used in the GP models to capture the periodic trends from non-periodic projection data. The initial guesses for the periodicity hyper-parameters of the GP models are intelligently derived from fast Fourier transform (FFT) analysis of the projection data. Additionally, we propose an unscented Kalman filter–Gaussian process (UKF-GP) fusion algorithm for target motion and inertia parameter estimation. The predicted projections from the GP models and their derivatives are used as the pseudo-measurements for UKF-GP during long-term occlusion. Results from Monte Carlo (MC) simulations demonstrate that, for varying tumbling frequencies, the UKF-GP can accurately estimate the target’s motion variables over hundreds of seconds, a capability the conventional UKF algorithm lacks. Full article
(This article belongs to the Section Physical Sensors)
Show Figures

Figure 1

Figure 1
<p>Schematic of the simulation scenario. The left spacecraft (chaser) is a cooperative spacecraft carrying a stereo-camera system, and the right one (target) is a torque-free, tumbling, non-cooperative space object. <math display="inline"><semantics> <mi mathvariant="script">I</mi> </semantics></math> is the inertial frame, and <math display="inline"><semantics> <mi mathvariant="script">B</mi> </semantics></math> is the body frame of the target that is parallel to the principal axes of the target. The target’s point features are indicated by the asterisk symbols.</p>
Full article ">Figure 2
<p>Schematic of the stereo-vision camera system.</p>
Full article ">Figure 3
<p>Flowchart of the UKF-GP algorithm.</p>
Full article ">Figure 4
<p>Results from the MC simulations for the GP models. (<b>a</b>) RMSE box plots of the predicted projections for 2000 s, and (<b>b</b>) the training time of the GP model.</p>
Full article ">Figure 5
<p>State variable estimation errors of UKF, Benchmark, and UKF-GP for <math display="inline"><semantics> <mrow> <msub> <mi>f</mi> <mi>T</mi> </msub> <mo>=</mo> <mn>0.025</mn> </mrow> </semantics></math> Hz.</p>
Full article ">Figure 5 Cont.
<p>State variable estimation errors of UKF, Benchmark, and UKF-GP for <math display="inline"><semantics> <mrow> <msub> <mi>f</mi> <mi>T</mi> </msub> <mo>=</mo> <mn>0.025</mn> </mrow> </semantics></math> Hz.</p>
Full article ">Figure 6
<p>State variable estimation errors of UKF, Benchmark, and UKF-GP for <math display="inline"><semantics> <mrow> <msub> <mi>f</mi> <mi>T</mi> </msub> <mo>=</mo> <mn>0.075</mn> </mrow> </semantics></math> Hz.</p>
Full article ">Figure 6 Cont.
<p>State variable estimation errors of UKF, Benchmark, and UKF-GP for <math display="inline"><semantics> <mrow> <msub> <mi>f</mi> <mi>T</mi> </msub> <mo>=</mo> <mn>0.075</mn> </mrow> </semantics></math> Hz.</p>
Full article ">Figure 7
<p>State variable estimation errors of UKF, Benchmark, and UKF-GP for <math display="inline"><semantics> <mrow> <msub> <mi>f</mi> <mi>T</mi> </msub> <mo>=</mo> <mn>0.125</mn> </mrow> </semantics></math> Hz.</p>
Full article ">Figure 7 Cont.
<p>State variable estimation errors of UKF, Benchmark, and UKF-GP for <math display="inline"><semantics> <mrow> <msub> <mi>f</mi> <mi>T</mi> </msub> <mo>=</mo> <mn>0.125</mn> </mrow> </semantics></math> Hz.</p>
Full article ">Figure 8
<p>State variable estimation errors of UKF, Benchmark, and UKF-GP for <math display="inline"><semantics> <mrow> <msub> <mi>f</mi> <mi>T</mi> </msub> <mo>=</mo> <mn>0.175</mn> </mrow> </semantics></math> Hz.</p>
Full article ">Figure 9
<p>RMSEs of the state estimation errors of UKF, Benchmark, and UKF-GP for 1500 s of occlusion from MC simulations. All figures have the same legend; therefore, the legend is only provided in (<b>a</b>).</p>
Full article ">
16 pages, 3922 KiB  
Article
Nicking Activity of M13 Bacteriophage Protein 2
by Esma Aybakan, Tanil Kocagoz and Ozge Can
Int. J. Mol. Sci. 2025, 26(2), 789; https://doi.org/10.3390/ijms26020789 - 18 Jan 2025
Viewed by 679
Abstract
Gene II Protein (Gp2/P2) is a nicking enzyme of the M13 bacteriophage that plays a role in the DNA replication of the viral genome. P2 recognizes a specific sequence at the f1 replication origin and nicks one of the strands and starts replication. [...] Read more.
Gene II Protein (Gp2/P2) is a nicking enzyme of the M13 bacteriophage that plays a role in the DNA replication of the viral genome. P2 recognizes a specific sequence at the f1 replication origin and nicks one of the strands and starts replication. This study was conducted to address the limitations of previous experiments, improve methodologies, and precisely determine the biochemical activity conditions of the P2 enzyme in vitro. For these purposes, the gene encoding P2 was cloned in Escherichia coli and expressed as a hybrid protein together with a green fluorescent protein (P2-GFP). P2-GFP was purified via metal affinity chromatography, and its nicking activity was determined by conversion of supercoiled DNA to open circular or linear forms. We discovered that, among the two loops of the f1 origin defined previously, P2 can recognize just the A1 loop. When a supercoiled plasmid containing the f1 origin was treated with P2-GFP, the plasmid was present in an open circular form, indicating that a nick was created on only one of the strands. However, when the A1 loop sequence was inserted into the 3′ ends of both strands by cloning a PCR product obtained by primers with the A1 loop sequence, the plasmid was linearized by treatment with P2-GFP, indicating that nicks were created on both strands. Certain infectious diseases are caused by single-stranded DNA viruses, and some of them have specific nicking enzymes that enable strand displacement and free 3′ end of a single strand that works as a primer for their replication mechanisms like M13 bacteriophages, such as parvovirus B19. Despite there being different host viruses such as bacteria and humans, their DNA replication mechanisms are very similar in this concept. Investigating the features of the P2-nicking enzyme may deepen the understanding of human pathogenic single-stranded viruses and facilitate the development of drugs that inhibit viral replication. Full article
(This article belongs to the Special Issue Bacteriophage: Molecular Ecology and Pharmacology, 2nd Edition)
Show Figures

Figure 1

Figure 1
<p>Rolling circle DNA amplification mechanism. Phage single-stranded circular DNA is converted to double-stranded replicative form (RF) by host enzymes after infection. P2 creates a nicking site at one strand of the RF. Then, DNA polymerase recognizes the nicked 3′ end and synthesizes the new DNA strand. P2 digests the new DNA strand again at the same specific recognition site. (Regenerated according to Sambrook (2001) [<a href="#B2-ijms-26-00789" class="html-bibr">2</a>] via Inkscape Project software, v.1.3.2.)</p>
Full article ">Figure 2
<p>P2 recognition site in M13 filamentous bacteriophage genome (NC_003287.2). (<b>A</b>) A1 and A2 are two loop structures of the recognition site, and the arrow indicates the nicking site. (<b>B</b>) Linearized DNA sequence of recognition site. Red inked nucleotides represent the required sequences for recognition of P2 from previous studies [<a href="#B15-ijms-26-00789" class="html-bibr">15</a>,<a href="#B16-ijms-26-00789" class="html-bibr">16</a>].</p>
Full article ">Figure 3
<p>Conformational change in DNA created by the P2 during the nicking process. (<b>A</b>) Representing of the DNA sequence segments (β, γ and δ) on the recognition site. (<b>B</b>) When P2 binds to the recognition site, it bends the DNA to create negative superhelicity. P2 nicks one of the DNA strands after the melting step which is the denaturing of strands. (Regenerated according to Horiuchi K. (1997) [<a href="#B20-ijms-26-00789" class="html-bibr">20</a>] via Inkscape Project Software, v.1.3.2.)</p>
Full article ">Figure 4
<p>Purified protein validation. (<b>A</b>) The purification fractions of P2-GFP samples were separated by SDS-PAGE. Lanes E1 and E2 represent the elution fractions; lane M represents the crude extract of inclusion bodies. The red arrow indicates P2-GFP (~73 kDa). (<b>B</b>) Fluorescent analysis of the purified sample by ChemiDoc gel imaging system (Bio-Rad, South Granville, NSW, Australia). Well 1 contains the purified sample, and well 2 contains the test control.</p>
Full article ">Figure 5
<p>Agarose gel images of substrate–product analysis with different conditions (<b>A</b>,<b>C</b>,<b>E</b>,<b>G</b>,<b>I</b>) and quantitative band analysis (<b>B</b>,<b>D</b>,<b>F</b>,<b>H</b>,<b>J</b>). OC, L, and SC are open circular, linear, and supercoiled DNA, respectively. OC-DNA was used as a product, and SC-DNA was used as a substrate. “Control 1”, “Control”, and “Control 2” in graphics show OC-DNA and SC-DNA amounts of control reaction samples, respectively. MW is 1 kb DNA Ladder (Genemark, Taichung, Taiwan).</p>
Full article ">Figure 6
<p>Temperature comparison of nicking reaction. (<b>A</b>) Agarose gel image of time course samples at 30 °C is labeled as “A” and room temperature (RT) is labeled as “B”. Time points are given from the 15th to 120th minute. Each time point is labeled with a number and temperature letter tag (A15 and B15 belong to 15th minute of the reaction sample at 30 °C and RT, respectively). Without P2-GFP enzyme control reactions represent “−” for each condition and time course. (<b>B</b>) Non-linear regression analysis of gel image. OC and SC represent open circular and supercoiled DNA, respectively. Controls show the band intensity of control samples. MW is 1 kb DNA Ladder, and each band is sized as kb.</p>
Full article ">Figure 7
<p>Kinetic analysis of P2-GFP. Open circular DNA intensity of different substrate concentrations and Michaelis–Menten equation for enzyme kinetics.</p>
Full article ">Figure 8
<p>Gel images of different plasmid nicking products. (<b>A</b>) Agarose gel image of pW, pA12, and pA1 nicking reactions. “+” labeled plasmids represent P2-GFP-added reactions; “−label represents control samples (without P2-GFP). “x” represents the digested plasmid that was treated with the XhoI restriction enzyme as a conformational control of linearized DNA on the gel. P2-GFP cut both strands of supercoiled plasmids through carrying P2 recognition sites at both. Red arrows indicate linearized DNAs by P2-GFP. (<b>B</b>) DNA-PAGE image of linear DNA substrates amplified by PCR. While “+” labeled F1, W, A12, and A1 DNA fragments represent P2-added reactions, “−” represents control samples of reactions which include F1, W, A12, and A1 DNA fragments without P2-GFP. “F1+” and “F1−” belong to PCR products of f1 origin as a natural substrate. L and SC are linear and supercoiled DNA, respectively.</p>
Full article ">
20 pages, 5586 KiB  
Article
Adaptive Navigation in Collaborative Robots: A Reinforcement Learning and Sensor Fusion Approach
by Rohit Tiwari, A. Srinivaas and Ratna Kishore Velamati
Appl. Syst. Innov. 2025, 8(1), 9; https://doi.org/10.3390/asi8010009 - 6 Jan 2025
Viewed by 862
Abstract
This paper presents a new approach for enhancing autonomous vehicle navigation and obstacle avoidance based on the integration of reinforcement learning with multiple sensors for navigation. The proposed system is designed to enable a reinforcement learning decision algorithm capable of making real-time decisions [...] Read more.
This paper presents a new approach for enhancing autonomous vehicle navigation and obstacle avoidance based on the integration of reinforcement learning with multiple sensors for navigation. The proposed system is designed to enable a reinforcement learning decision algorithm capable of making real-time decisions in aiding the adaptive capability of a vehicle. This method was tested on a prototype vehicle with navigation based on a Ublox Neo 6M GPS and a three-axis magnetometer, while for obstacle detection, this system uses three ultrasonic sensors. The use of a model-free reinforcement learning algorithm and use of an effective sensor for obstacle avoidance (instead of LiDAR and a camera) provides the proposed system advantage in terms of computational requirements, adaptability, and overall cost. Our experiments show that the proposed method improves navigation accuracy substantially and significantly advances the ability to avoid obstacles. The prototype vehicle adapts very well to the conditions of the testing track. Further, the data logs from the vehicle were analyzed to check the performance. It is this cost-effective and adaptable nature of the system that holds some promise toward a solution in situations where human intervention is not feasible, or even possible, due to either danger or remoteness. In general, this research showed how the application of reinforcement learning combined with sensor fusion enhances autonomous navigation and makes vehicles perform more reliably and intelligently in dynamic environments. Full article
(This article belongs to the Special Issue Advancements in Deep Learning and Its Applications)
Show Figures

Figure 1

Figure 1
<p>Cobot features.</p>
Full article ">Figure 2
<p>Overview of the RL Cobot system.</p>
Full article ">Figure 3
<p>Navigation algorithm flow diagram.</p>
Full article ">Figure 4
<p>Obstacle avoidance algorithm flow diagram.</p>
Full article ">Figure 5
<p>System architecture diagram.</p>
Full article ">Figure 6
<p>U-center interface.</p>
Full article ">Figure 7
<p>Test track satellite view.</p>
Full article ">Figure 8
<p>Path mapping from test vehicle’s decisions.</p>
Full article ">Figure 9
<p>Polar plot of heading angle data(red: high density; blue: data points).</p>
Full article ">Figure 10
<p>Bar graph of heading angle data (red: desired values; blue: data points).</p>
Full article ">Figure 11
<p>Test vehicle.</p>
Full article ">Figure 12
<p>Change in decision weights.</p>
Full article ">
14 pages, 2690 KiB  
Article
Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes
by Sirima Sangkapat, Rattiporn Boonnop, Jeerawat Pimta, Napason Chabang, Bodee Nutho, Promsuk Jutabha and Sunhapas Soodvilai
Pharmaceuticals 2025, 18(1), 42; https://doi.org/10.3390/ph18010042 - 1 Jan 2025
Viewed by 768
Abstract
Background/Objectives: Pinocembrin is a promising drug candidate for treating ischemic stroke. The interaction of pinocembrin with drug transporters and drug-metabolizing enzymes is not fully revealed. The present study aims to evaluate the interaction potential of pinocembrin with cytochrome P450 (CYP450: CYP2B6, CYP2C9, [...] Read more.
Background/Objectives: Pinocembrin is a promising drug candidate for treating ischemic stroke. The interaction of pinocembrin with drug transporters and drug-metabolizing enzymes is not fully revealed. The present study aims to evaluate the interaction potential of pinocembrin with cytochrome P450 (CYP450: CYP2B6, CYP2C9, and CYP2C19) and drug transporters including organic anion transporters (OAT1 and OAT3), organic cation transporters (OCT1 and OCT2), multidrug and toxin extrusion (MATE1 and MATE2, P-glycoprotein (P-gp), and breast cancer resistance protein (BCRP). Methods: The interactions of pinocembrin on drug transporters were determined in the Madin–Darby canine kidney (MDCK) cells overexpressing human (h)OAT1 or hOAT3 and in the Chinese hamster ovary (CHO-K1) cells overexpressing hOCT1, hOCT2, hMATE1, or hMATE2. The interactions of pinocembrin with BCRP and P-glycoprotein were determined in Caco-2 cells. The CYP450 enzyme inhibitory activity was assessed by a cell-free CYP450 screening assay. Results: Pinocembrin effectively inhibited the function of OAT1 and OAT3 with a half-inhibitory concentration (IC50) and inhibitory constant (Ki) of ∼2 μM. In addition, it attenuated the toxicity of tenofovir, a substrate of hOAT1, in cells overexpressing hOAT1. Based on the kinetic study and molecular docking, pinocembrin inhibited OAT1 and OAT3 via a competitive inhibition. In contrast to hOAT1 and hOAT3, pinocembrin did not significantly inhibit the function of OCT1, OCT2, MATE1, MATE2, BCRP, and P-glycoprotein. In addition, pinocembrin potently inhibited the activity of CYP2C19, whereas it exhibited low inhibitory potency on CYP2B6 and CYP2C9. Conclusions: The present study reveals the potential drug interaction of pinocembrin on OAT1, OAT3, and CYP2C19. Co-administration with pinocembrin might affect OAT1-, OAT3-, and CYP2C19-mediated drug pharmacokinetic profiles. Full article
(This article belongs to the Section Natural Products)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Effect of pinocembrin on the function of P-gp, BCRP, hOAT1, hOAT3, hOCT1, hOCT2, hMATE1, and hMATE2. (<b>A</b>) Transport function of P-gp and BCRP, (<b>B</b>) hOAT1 and hOAT3, (<b>C</b>) hOCT1 and hOCT2, and (<b>D</b>) hMATE1 and hMATE3. Probenecid and estrone sulfate were positive controls for hOAT1 and hOAT3 inhibition. Tetraethylammonium (TPeA) is an inhibitor of hOCT1, hOCT2, hMATE1, and hMATE2. The data are expressed as the mean ± S.D. of % of vehicle control from three experiments. * <span class="html-italic">p</span> &lt; 0.05 compared with the control.</p>
Full article ">Figure 2
<p>Inhibitory potency of pinocembrin on the transport function of hOAT1 and hOAT3. (<b>A</b>) hOAT1-MDCK cells and (<b>B</b>) hOAT3-MDCK cells incubated with 6-CF (10 µM) in the presence of pinocembrin for 20 min. Uptakes of 6-CF are calculated as % of control (no pinocembrin) and represented as the mean ± S.D. from three experiments.</p>
Full article ">Figure 3
<p>Kinetic studies on hOAT1- and hOAT3-mediated 6-CF uptake. The uptake of 6-CF (1–100 μM) for 20 min in hOAT1-MDCK cells (<b>A</b>) and hOAT3-MDCK cells (<b>B</b>) in the presence of the vehicle and 5 μM pinocembrin. The Michaelis–Menten diagrams and Eadie–Hofstee plots of 6-CF uptake are shown.</p>
Full article ">Figure 4
<p>Binding prediction of pinocembrin with hOAT1 and hOAT3. (<b>A</b>) Chemical structure of pinocembrin. (<b>B</b>,<b>C</b>) The molecular docking results of pinocembrin, in complex with hOAT1 and hOAT3, represented as 3D close-up views of the substrate-/inhibitor-binding site and 2D interaction diagrams of ligand–hOAT1/hOAT3 complexes.</p>
Full article ">Figure 5
<p>The effect of pinocembrin treatment on hOAT1 and hOAT3. The hOAT1-MDCK and hOAT3-MDCK cells were incubated with pinocembrin for 48 h, followed by the measurement of the hOAT1 and hOAT3 transport function and cell viability. The data are the mean ± S.D. of three experiments. * <span class="html-italic">p</span> &lt; 0.05 compared with control.</p>
Full article ">Figure 6
<p>The effect of pinocembrin treatment on hOAT1 and hOAT3. The hOAT1-MDCK and hOAT3-MDCK cells were incubated with indicated conditions for 48 h, then the viability of hOAT1-MDCK and hOAT3-MDCK cells was measured. Data are the mean ± S.D. of three experiments. * <span class="html-italic">p</span> &lt; 0.05 compared with vehicle and <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 compared with tenofovir-treated cells.</p>
Full article ">Figure 7
<p>Effects of pinocembrin on the activity of CYP enzymes. (<b>A</b>) Inhibitory effect of pinocembrin on CYP2B6, CYP2C9, and CYP2C19. (<b>B</b>) Molecular docking result of pinocembrin in complex with human CYP2C19 (3D close-up view of active site of CYP2C19 and 2D interaction diagram of pinocembrin–CYP2C19 complex).</p>
Full article ">
15 pages, 5551 KiB  
Article
A Comparative In Vitro Digestion Study of Three Lipid Delivery Systems for Arachidonic and Docosahexaenoic Acids Intended to Be Used for Preterm Infants
by Blanca Pardo de Donlebún, Assamae Chabni, Celia Bañares and Carlos F. Torres
Molecules 2024, 29(24), 6032; https://doi.org/10.3390/molecules29246032 - 21 Dec 2024
Viewed by 642
Abstract
It is well stablished that docosahexaenoic (DHA) and arachidonic (ARA) acids fulfill relevant biological activities, especially in newborns. However, oils containing these fatty acids are not always optimally digestible. To address this, various formulation strategies and lipid delivery systems have been developed. This [...] Read more.
It is well stablished that docosahexaenoic (DHA) and arachidonic (ARA) acids fulfill relevant biological activities, especially in newborns. However, oils containing these fatty acids are not always optimally digestible. To address this, various formulation strategies and lipid delivery systems have been developed. This study compares the following three formulations in an in vitro digestion model to assess bioaccessibility: Enfamil® DHA & ARA (Mead Johnson & Company), an emulsion of FormulaidTM, AquaCelle®, and pasteurized donated human milk, and a previously characterized enzymatic glycerolysis product (GP) of ARA oil and microalgae oil in a 2:1 (w:w) ratio. To evaluate digestibility, parameters such as the percentage of oily phase (OP), micellar phase (MP), free fatty acids, and monoacylglycerols in the digestion product (DP) were considered. Additionally, diacylglycerol content in the MP can be used as an indirect marker of the emulsification capacity of the DP, and consequently, as an indicator of bioaccessibility. The GP demonstrated the highest bioaccessibility, with a DP containing more than 80% MP (<14% OP), rich in free fatty acids (60%) and monoacylglycerols (17%). Furthermore, more than 40% of total diacylglycerols were present in MP, highlighting GPs’ potential as a superior delivery system for DHA and ARA in preterm infant formulations. Full article
Show Figures

Figure 1

Figure 1
<p>Time course of <span class="html-italic">in vitro</span> gastric and intestinal digestion of the emulsion of Formulaid<sup>TM</sup>, AquaCelle<sup>®</sup>, and donated breast milk (<b>A</b>), commercial Enfamil<sup>®</sup> DHA &amp; ARA (<b>B</b>), and the glycerolysis product with an ARA to DHA ratio of two to one [<a href="#B11-molecules-29-06032" class="html-bibr">11</a>] (<b>C</b>). <span class="html-fig-inline" id="molecules-29-06032-i001"><img alt="Molecules 29 06032 i001" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i001.png"/></span> FFA: free fatty acid, <span class="html-fig-inline" id="molecules-29-06032-i002"><img alt="Molecules 29 06032 i002" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i002.png"/></span> MAG: monoacylglyceride, <span class="html-fig-inline" id="molecules-29-06032-i003"><img alt="Molecules 29 06032 i003" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i003.png"/></span> cholesterol, <span class="html-fig-inline" id="molecules-29-06032-i004"><img alt="Molecules 29 06032 i004" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i004.png"/></span> DAG: diacylglyceride, <span class="html-fig-inline" id="molecules-29-06032-i005"><img alt="Molecules 29 06032 i005" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i005.png"/></span> TAG: triacylglyceride.</p>
Full article ">Figure 2
<p>Linear regression of logarithmic total glyceride vs. time for the Formulaid<sup>TM</sup>, AquaCelle<sup>®</sup>, and donated breast milk emulsion (triangles), Enfamil<sup>®</sup> DHA &amp; ARA (circles), and enzymatic glycerolysis product (squares).</p>
Full article ">Figure 3
<p>Phase compositions after <span class="html-italic">in vitro</span> digestion of the Formulaid<sup>TM</sup>, AquaCelle<sup>®</sup>, and donated breast milk emulsion (<b>A</b>), and commercial Enfamil<sup>®</sup> DHA &amp; ARA (<b>B</b>). <span class="html-fig-inline" id="molecules-29-06032-i006"><img alt="Molecules 29 06032 i006" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i006.png"/></span> FFA: free fatty acid, <span class="html-fig-inline" id="molecules-29-06032-i007"><img alt="Molecules 29 06032 i007" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i007.png"/></span> MAG: monoacylglyceride, <span class="html-fig-inline" id="molecules-29-06032-i008"><img alt="Molecules 29 06032 i008" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i008.png"/></span> cholesterol, <span class="html-fig-inline" id="molecules-29-06032-i009"><img alt="Molecules 29 06032 i009" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i009.png"/></span> DAG: diacylglyceride, <span class="html-fig-inline" id="molecules-29-06032-i010"><img alt="Molecules 29 06032 i010" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i010.png"/></span> TAG: triacylglyceride. <span class="html-fig-inline" id="molecules-29-06032-i011"><img alt="Molecules 29 06032 i011" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i011.png"/></span> OP: oil phase, <span class="html-fig-inline" id="molecules-29-06032-i012"><img alt="Molecules 29 06032 i012" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i012.png"/></span> MP: micellar phase, <span class="html-fig-inline" id="molecules-29-06032-i013"><img alt="Molecules 29 06032 i013" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i013.png"/></span> PP: precipitate phase.</p>
Full article ">Figure 4
<p>Distribution of each lipid compound among the different phases of digestion product (DP) from the Formulaid<sup>TM</sup>, AquaCelle<sup>®</sup>, and donated breast milk emulsion (<b>A</b>), and commercial Enfamil<sup>®</sup> DHA &amp; ARA (<b>B</b>). <span class="html-fig-inline" id="molecules-29-06032-i006"><img alt="Molecules 29 06032 i006" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i006.png"/></span> FFA: free fatty acid, <span class="html-fig-inline" id="molecules-29-06032-i007"><img alt="Molecules 29 06032 i007" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i007.png"/></span> MAG: monoacylglyceride, <span class="html-fig-inline" id="molecules-29-06032-i008"><img alt="Molecules 29 06032 i008" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i008.png"/></span> cholesterol, <span class="html-fig-inline" id="molecules-29-06032-i009"><img alt="Molecules 29 06032 i009" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i009.png"/></span> DAG: diacylglyceride, <span class="html-fig-inline" id="molecules-29-06032-i010"><img alt="Molecules 29 06032 i010" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i010.png"/></span> TAG: triacylglyceride. <span class="html-fig-inline" id="molecules-29-06032-i011"><img alt="Molecules 29 06032 i011" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i011.png"/></span> OP: oil phase, <span class="html-fig-inline" id="molecules-29-06032-i012"><img alt="Molecules 29 06032 i012" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i012.png"/></span> MP: micellar phase, <span class="html-fig-inline" id="molecules-29-06032-i013"><img alt="Molecules 29 06032 i013" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i013.png"/></span> PP: precipitate phase.</p>
Full article ">Figure 5
<p>Phase compositions after <span class="html-italic">in vitro</span> digestion (<b>A</b>) and the distribution of each lipid compound among the different phases (<b>B</b>) of enzymatic glycerolysis product DP. <span class="html-fig-inline" id="molecules-29-06032-i006"><img alt="Molecules 29 06032 i006" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i006.png"/></span> FFA: free fatty acid, <span class="html-fig-inline" id="molecules-29-06032-i007"><img alt="Molecules 29 06032 i007" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i007.png"/></span> MAG: monoacylglyceride, <span class="html-fig-inline" id="molecules-29-06032-i008"><img alt="Molecules 29 06032 i008" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i008.png"/></span> cholesterol, <span class="html-fig-inline" id="molecules-29-06032-i009"><img alt="Molecules 29 06032 i009" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i009.png"/></span> DAG: diacylglyceride, <span class="html-fig-inline" id="molecules-29-06032-i010"><img alt="Molecules 29 06032 i010" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i010.png"/></span> TAG: triacylglyceride. <span class="html-fig-inline" id="molecules-29-06032-i011"><img alt="Molecules 29 06032 i011" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i011.png"/></span> OP: oil phase, <span class="html-fig-inline" id="molecules-29-06032-i012"><img alt="Molecules 29 06032 i012" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i012.png"/></span> MP: micellar phase, <span class="html-fig-inline" id="molecules-29-06032-i013"><img alt="Molecules 29 06032 i013" src="/molecules/molecules-29-06032/article_deploy/html/images/molecules-29-06032-i013.png"/></span> PP: precipitate phase.</p>
Full article ">Figure 6
<p>Particle size distribution of the commercial Enfamil<sup>®</sup> DHA &amp; ARA micellar phase (dots) and glycerolysis product micellar phase (line).</p>
Full article ">
21 pages, 2028 KiB  
Article
Predictive and Prognostic Values of Glycoprotein 96, Androgen Receptors, and Extranodal Extension in Sentinel Lymph Node-Positive Breast Cancer: An Immunohistochemical Retrospective Study
by Tihana Klarica Gembić, Damir Grebić, Tamara Gulić, Mijo Golemac and Manuela Avirović
J. Clin. Med. 2024, 13(24), 7665; https://doi.org/10.3390/jcm13247665 - 16 Dec 2024
Viewed by 457
Abstract
Objectives: In this paper, we investigate the association of glycoprotein 96 (GP96) and androgen receptor (AR) expression with clinicopathological factors, additional axillary lymph node burden, and their potential role in predicting 5-year overall survival (OS) and disease-free survival (DFS) in breast cancer [...] Read more.
Objectives: In this paper, we investigate the association of glycoprotein 96 (GP96) and androgen receptor (AR) expression with clinicopathological factors, additional axillary lymph node burden, and their potential role in predicting 5-year overall survival (OS) and disease-free survival (DFS) in breast cancer (BC) patients with sentinel lymph node (SLN) involvement. We also explore the prognostic value of the presence of extranodal extension (ENE) in SLN. Methods: We retrospectively enrolled 107 female patients with cT1-T2 invasive BC and positive SLN biopsy. GP96 and AR expression were immunohistochemically evaluated on tissue microarrays constructed from two 2 mm diameter cores of formalin-fixed paraffin-embedded tumor tissues from each patient. ENE in SLN was measured in the highest (HD-ENE) and widest diameter (WD-ENE). Relative GP96 gene expression was determined using real-time quantitative PCR. Results: The analysis revealed ENE in SLN as the strongest predictive factor for non-SLN metastases. Patients with WD-ENE > HD-ENE had a higher risk of non-SLN metastases and worse DFS compared to those with WD-ENE ≤ HD-ENE. High GP96 expression was associated with a greater relative risk for locoregional recurrence but showed no significant impact on OS or DFS. Histological grade 3, extensive intraductal component (EIC), higher lymph node ratio (LNR), and negative AR were associated with worse DFS, while age, histological grade 3, EIC, and higher LNR were independent predictors of OS. GP96 mRNA levels were elevated in BC tissue compared to normal breast tissue. Conclusions: ENE in SLN is the strongest predictor of non-SLN involvement and could also have prognostic significance. While GP96 expression does not influence survival outcomes, AR expression could be used as a valuable biomarker in the follow-up of BC patients. Full article
(This article belongs to the Section Oncology)
Show Figures

Figure 1

Figure 1
<p>Representative images of immunohistochemical staining for androgen receptors (ARs) and glycoprotein 96 (GP96) in invasive breast cancer tissues. Negative expression of AR (<b>A</b>) and positive nuclear staining for AR (<b>B</b>). Weakly positive expression of GP96 (<b>C</b>), moderately positive expression (<b>D</b>), and strongly positive expression (<b>E</b>). Scale bar, 100 µm.</p>
Full article ">Figure 1 Cont.
<p>Representative images of immunohistochemical staining for androgen receptors (ARs) and glycoprotein 96 (GP96) in invasive breast cancer tissues. Negative expression of AR (<b>A</b>) and positive nuclear staining for AR (<b>B</b>). Weakly positive expression of GP96 (<b>C</b>), moderately positive expression (<b>D</b>), and strongly positive expression (<b>E</b>). Scale bar, 100 µm.</p>
Full article ">Figure 2
<p>The Kaplan–Meier survival curves for overall survival (OS) and disease-free survival (DFS) according to different extranodal extension (ENE) subgroups, androgen receptor (AR) expression, and glycoprotein 96 (GP96) expression. OS survival rates comparing WD-ENE ≤ HD-ENE vs. no ENE (<b>A</b>) and WD-ENE &gt; HD-ENE versus no ENE (<b>B</b>). DFS survival rates comparing WD-ENE ≤ HD-ENE vs. no ENE (<b>C</b>) and WD-ENE &gt; HD-ENE vs. no ENE (<b>D</b>). OS survival rates comparing AR ≥ 10% vs. AR &lt; 10% (<b>E</b>) and DFS survival rates comparing AR ≥ 10% vs. AR &lt; 10% (<b>F</b>). OS survival rates comparing GP96 H-score &gt; 200 vs. GP96 H-score ≤ 200 (<b>G</b>) and DFS survival rates comparing GP96 H-score &gt; 200 vs. GP96 H-score ≤ 200 (<b>H</b>).</p>
Full article ">Figure 2 Cont.
<p>The Kaplan–Meier survival curves for overall survival (OS) and disease-free survival (DFS) according to different extranodal extension (ENE) subgroups, androgen receptor (AR) expression, and glycoprotein 96 (GP96) expression. OS survival rates comparing WD-ENE ≤ HD-ENE vs. no ENE (<b>A</b>) and WD-ENE &gt; HD-ENE versus no ENE (<b>B</b>). DFS survival rates comparing WD-ENE ≤ HD-ENE vs. no ENE (<b>C</b>) and WD-ENE &gt; HD-ENE vs. no ENE (<b>D</b>). OS survival rates comparing AR ≥ 10% vs. AR &lt; 10% (<b>E</b>) and DFS survival rates comparing AR ≥ 10% vs. AR &lt; 10% (<b>F</b>). OS survival rates comparing GP96 H-score &gt; 200 vs. GP96 H-score ≤ 200 (<b>G</b>) and DFS survival rates comparing GP96 H-score &gt; 200 vs. GP96 H-score ≤ 200 (<b>H</b>).</p>
Full article ">
14 pages, 337 KiB  
Article
Limiting Performance of Radar-Based Positioning Solutions for the Automotive Scenario
by Francesco Bandiera and Giuseppe Ricci
Sensors 2024, 24(24), 7940; https://doi.org/10.3390/s24247940 - 12 Dec 2024
Viewed by 408
Abstract
Road safety applications for automotive scenarios rely on the ability to estimate vehicle positions with high precision. Global navigation satellite systems (GNSS) and, in particular, the global positioning system (GPS), are commonly used for self localization. But, especially in urban vehicular scenarios, due [...] Read more.
Road safety applications for automotive scenarios rely on the ability to estimate vehicle positions with high precision. Global navigation satellite systems (GNSS) and, in particular, the global positioning system (GPS), are commonly used for self localization. But, especially in urban vehicular scenarios, due to obstructions, they may not provide the requirements for crucial position-based applications. In this paper, we investigate the potential of GPS-free positioning schemes and, in particular, we compute the ultimate performance, i.e., Cramér–Rao lower bounds (CRLB), of localization schemes in which each vehicle estimates its position exploiting range and/or angle measurements of an assigned set of landmarks with a known position. Full article
(This article belongs to the Section Radar Sensors)
Show Figures

Figure 1

Figure 1
<p>Geometric model of the system with only one landmark. Vehicle is in point <span class="html-italic">P</span> and the angle <math display="inline"><semantics> <msub> <mi>θ</mi> <mi>i</mi> </msub> </semantics></math> is measured on the <math display="inline"><semantics> <mrow> <mi>x</mi> <mo>−</mo> <mi>y</mi> </mrow> </semantics></math> plane.</p>
Full article ">Figure 2
<p>RMS estimation error curves for <math display="inline"><semantics> <mrow> <mi>N</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mi>d</mi> <mo>=</mo> <mn>10</mn> </mrow> </semantics></math> m, <math display="inline"><semantics> <mrow> <msub> <mi>x</mi> <mn>0</mn> </msub> <mo>=</mo> <mn>0</mn> </mrow> </semantics></math> m. (1,1)th: red, (2,2)th: black; solid: range and azimuth measurements, dashed: range measurements only, dash-dotted: azimuth measurements only.</p>
Full article ">Figure 3
<p>RMS estimation error curves for <math display="inline"><semantics> <mrow> <mi>N</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mi>d</mi> <mo>=</mo> <mn>10</mn> </mrow> </semantics></math> m, <math display="inline"><semantics> <mrow> <msub> <mi>x</mi> <mn>0</mn> </msub> <mo>=</mo> <mo>+</mo> <mn>9</mn> </mrow> </semantics></math> m. (1,1)th: red, (2,2)th: black; solid: range and azimuth measurements, dashed: range measurements only, dash-dotted: azimuth measurements only.</p>
Full article ">Figure 4
<p>RMS estimation error curves for <math display="inline"><semantics> <mrow> <mi>N</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mi>d</mi> <mo>=</mo> <mn>5</mn> </mrow> </semantics></math> m, <math display="inline"><semantics> <mrow> <msub> <mi>x</mi> <mn>0</mn> </msub> <mo>=</mo> <mn>0</mn> </mrow> </semantics></math> m. (1,1)th: red, (2,2)th: black; solid: range and azimuth measurements, dashed: range measurements only, dash-dotted: azimuth measurements only.</p>
Full article ">Figure 5
<p>RMS estimation error curves for <math display="inline"><semantics> <mrow> <mi>N</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mi>d</mi> <mo>=</mo> <mn>5</mn> </mrow> </semantics></math> m, <math display="inline"><semantics> <mrow> <msub> <mi>x</mi> <mn>0</mn> </msub> <mo>=</mo> <mo>+</mo> <mn>4.5</mn> </mrow> </semantics></math> m. (1,1)th: red, (2,2)th: black; solid: range and azimuth measurements, dashed: range measurements only, dash-dotted: azimuth measurements only.</p>
Full article ">Figure 6
<p>RMS estimation error curves for <math display="inline"><semantics> <mrow> <mi>N</mi> <mo>=</mo> <mn>2</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mi>d</mi> <mo>=</mo> <mn>10</mn> </mrow> </semantics></math> m, <math display="inline"><semantics> <mrow> <msub> <mi>x</mi> <mn>0</mn> </msub> <mo>=</mo> <mn>0</mn> </mrow> </semantics></math> m. (1,1)th: red, (2,2)th: black; solid: range and azimuth measurements, dashed: range measurements only, dash-dotted: azimuth measurements only.</p>
Full article ">Figure 7
<p>RMS estimation error curves for <math display="inline"><semantics> <mrow> <mi>N</mi> <mo>=</mo> <mn>2</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mi>d</mi> <mo>=</mo> <mn>10</mn> </mrow> </semantics></math> m, <math display="inline"><semantics> <mrow> <msub> <mi>x</mi> <mn>0</mn> </msub> <mo>=</mo> <mn>9</mn> </mrow> </semantics></math> m. (1,1)th: red, (2,2)th: black; solid: range and azimuth measurements, dashed: range measurements only, dash-dotted: azimuth measurements only.</p>
Full article ">Figure 8
<p>RMS estimation error vs. <math display="inline"><semantics> <msub> <mi>σ</mi> <mi>r</mi> </msub> </semantics></math> (in m), for <math display="inline"><semantics> <mrow> <mi>N</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mi>d</mi> <mo>=</mo> <mn>10</mn> </mrow> </semantics></math> m, <math display="inline"><semantics> <mrow> <mi>P</mi> <mo>(</mo> <mn>0</mn> <mo>,</mo> <mo>−</mo> <mn>45</mn> <mo>)</mo> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <msub> <mi>σ</mi> <mi>θ</mi> </msub> <mo>=</mo> <mn>2</mn> <mo>°</mo> </mrow> </semantics></math>. (1,1)th: red, (2,2)th: black; solid: range and azimuth measurements, dashed: range measurements only, dash-dotted: azimuth measurements only.</p>
Full article ">Figure 9
<p>RMS estimation error vs. <math display="inline"><semantics> <msub> <mi>σ</mi> <mi>θ</mi> </msub> </semantics></math> (in degrees), for <math display="inline"><semantics> <mrow> <mi>N</mi> <mo>=</mo> <mn>4</mn> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <mi>d</mi> <mo>=</mo> <mn>10</mn> </mrow> </semantics></math> m, <math display="inline"><semantics> <mrow> <mi>P</mi> <mo>(</mo> <mn>0</mn> <mo>,</mo> <mo>−</mo> <mn>45</mn> <mo>)</mo> </mrow> </semantics></math>, <math display="inline"><semantics> <mrow> <msub> <mi>σ</mi> <mi>r</mi> </msub> <mo>=</mo> <mn>1</mn> </mrow> </semantics></math> m. (1,1)th: red, (2,2)th: black; solid: range and azimuth measurements, dashed: range measurements only, dash-dotted: azimuth measurements only.</p>
Full article ">
11 pages, 1666 KiB  
Article
Immune-Modified Glasgow Prognostic Score Predicts Therapeutic Effect of Pembrolizumab in Recurrent and Metastatic Head and Neck Cancer
by Natsuko Ueda, Masashi Kuroki, Hirofumi Shibata, Manato Matsubara, Saki Akita, Tatsuhiko Yamada, Rina Kato, Ryota Iinuma, Ryo Kawaura, Hiroshi Okuda, Kosuke Terazawa, Kenichi Mori, Ken Saijo, Toshimitsu Ohashi and Takenori Ogawa
Cancers 2024, 16(23), 4056; https://doi.org/10.3390/cancers16234056 - 3 Dec 2024
Viewed by 1061
Abstract
Background: Previously, we proposed that the immune-modified Glasgow Prognostic Score (imGPS), which adds the lymphocyte count to the mGPS, is helpful as a prognostic marker for patients with head and neck squamous cell carcinoma. In this study, we investigated the imGPS as a [...] Read more.
Background: Previously, we proposed that the immune-modified Glasgow Prognostic Score (imGPS), which adds the lymphocyte count to the mGPS, is helpful as a prognostic marker for patients with head and neck squamous cell carcinoma. In this study, we investigated the imGPS as a marker for the therapeutic effect of pembrolizumab in treating recurrent and metastatic head and neck cancer (RMHNC). Methods: This study included RMHNC patients who were treated with pembrolizumab from December 2019 to April 2024. ALB, CRP, lymphocyte counts, neutrophil-to-lymphocyte ratios (NLRs), mGPSs, and imGPSs were extracted as biomarkers, and the response rate and prognosis were analyzed for each. Results: A total of 54 patients were enrolled. Lymphocyte counts were correlated with the overall response rates (ORRs) (p = 0.0082). Although the mGPS did not show significant differences in ORRs, imGPSs revealed a significant difference (p = 0.013). CRP, ALB, and lymphocyte counts were correlated with overall survival (OS) and/or progression-free survival (PFS). NLRs, mGPSs, and imGPSs were also correlated with OS and/or PFS, with imGPSs showing the greatest area under the curve (OS; AUC = 0.795, PFS; AUC = 0.754). Conclusions: This study demonstrates that the imGPS is an excellent predictive marker for the therapeutic effect and prognosis of pembrolizumab for RMHNC. The imGPS can be employed with daily blood tests, highlighting the potential to forecast the impact of the ICI with high reliability. Full article
Show Figures

Figure 1

Figure 1
<p>A predictive marker for the therapeutic effect of pembrolizumab. Overall response rates were evaluated for each of the following eight biomarkers: CRP (≦1; <span class="html-italic">n</span> = 37, &lt;1; <span class="html-italic">n</span> = 17), ALB (&lt;3.5; <span class="html-italic">n</span> = 23, ≦3.5; <span class="html-italic">n</span> = 31), lymphocytes (≦1250; <span class="html-italic">n</span> = 17, &lt;1250; 37), NLR (&lt;6.589; <span class="html-italic">n</span> = 38, ≦6.589; <span class="html-italic">n</span> = 16), mGPS (0; <span class="html-italic">n</span> = 37, 1; <span class="html-italic">n</span> = 5, 2; <span class="html-italic">n</span> = 12), imGPS (0; <span class="html-italic">n</span> = 14, 1; <span class="html-italic">n</span> = 21, 2; <span class="html-italic">n</span> = 9, 3; <span class="html-italic">n</span> = 10). NLR: neutrophil-to-lymphocyte ratio, mGPS: modified Glasgow Prognostic Score, imGPS: immune-modified GPS. **, <span class="html-italic">p</span> &lt; 0.01; *, <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 2
<p>Prognosis of all cases. OS: overall survival, PFS: progression-free survival.</p>
Full article ">Figure 3
<p>A predictive marker for prognosis of pembrolizumab (CRP, ALB, lymphocytes). OS and progression-free survival (PFS) were evaluated according to CPR and ALB levels and lymphocyte counts; CRP (≦1; <span class="html-italic">n</span> = 37, 1&lt;; <span class="html-italic">n</span> = 17), ALB (&lt;3.5; <span class="html-italic">n</span> = 23, ≦3.5; <span class="html-italic">n</span> = 31), lymphocytes (≦1250; <span class="html-italic">n</span> = 17, &lt;1250; 37). OS: overall survival, PFS: progression-free survival. ***, <span class="html-italic">p</span> &lt; 0.001; **, <span class="html-italic">p</span> &lt; 0.01; *, <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 4
<p>A predictive marker for prognosis of pembrolizumab (NLR, mGPS, imGPS). OS and PFS were evaluated according to NLRs, mGPSs, and imGPSs; NLR (&lt;6.589; <span class="html-italic">n</span> = 38, ≦6.589; <span class="html-italic">n</span> = 16), mGPS (0; <span class="html-italic">n</span> = 37, 1; <span class="html-italic">n</span> = 5, 2; <span class="html-italic">n</span> = 12), imGPS (0; <span class="html-italic">n</span> = 14, 1; <span class="html-italic">n</span> = 21, 2; <span class="html-italic">n</span> = 9, 3; <span class="html-italic">n</span> = 10). OS: overall survival, PFS: progression-free survival, NLR: neutrophil-to-lymphocyte ratio, mGPS: modified Glasgow Prognostic Score, imGPS: immune-modified GPS. **, <span class="html-italic">p</span> &lt; 0.01; *, <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">
16 pages, 1724 KiB  
Article
Green Manure Rotation Combined with Biochar Application Improves Yield and Economic Stability of Continuous Cropping of Peppers in Southwest China
by Meng Zhang, Yanling Liu, Xiaofeng Gu, Quanquan Wei, Lingling Liu and Jiulan Gou
Plants 2024, 13(23), 3387; https://doi.org/10.3390/plants13233387 - 2 Dec 2024
Viewed by 806
Abstract
Crop rotation is widely recognized as a key strategy to mitigate the adverse effects associated with continuous cropping. Recent studies have demonstrated that biochar has a significant potential for preventing and controlling these challenges. However, the ameliorative effects of green manure rotation and [...] Read more.
Crop rotation is widely recognized as a key strategy to mitigate the adverse effects associated with continuous cropping. Recent studies have demonstrated that biochar has a significant potential for preventing and controlling these challenges. However, the ameliorative effects of green manure rotation and biochar application on continuous pepper cultivation in the karst mountainous regions of Southwest China remain largely unexplored. To address this gap, a field experiment was conducted from 2020 to 2023 to investigate the effects of green manure rotation and biochar application on the continuous cropping of peppers. The experiment consisted of five treatments: CK (no green manure and no biochar), WP (winter fallow and conventional pepper production with chemical fertilization), GP (green manure and pepper rotation, the amount of fresh green manure returned to the field was about 15 t·ha−1), WP + B (winter fallow and pepper rotation with 1500 kg·ha−1 of biochar applied during the pepper season), and GP + B (green manure and pepper rotation with 1500 kg·ha−1 of biochar applied during the pepper season, the amount of fresh green manure returned to the field was about 15 t·ha−1). The results showed that all the improved measures (GP, WP + B, GP + B) increased the yield of fresh pepper and dry pepper by 26.97–72.98% and 20.96–65.70%, respectively, and the yield of dry pod pepper increased by 14.69–40.63% and 21.44–73.29% in 2021 to 2023, respectively, and significantly improved the yield stability and sustainability of continuous cropping of peppers compared with WP treatments. In addition, green manure rotation or biochar application alone or in combination enhanced the nutritional quality of pepper fruits by increasing the content of free amino acids (8.62–19.42%), reducing sugars (15.30–34.62%) and vitamin C (26.19–43.52), and decreasing the nitrate content (26.93–40.17%). Furthermore, the application of green manure rotation or biochar alone or in combination significantly improved the absorption of nitrogen (23.73–60.23%), phosphorus (18.12–61.71%), and potassium (20.57–61.48%) nutrients in the continuous cropping of peppers, which contributed to the improvement of fertilizer use efficiency. Notably, GP + B treatment not only improved the yield and quality of continuous cropping peppers but also resulted in higher production value and net income compared to the GP and WP + B treatments. In conclusion, the combination of green manure rotation and biochar application represents an effective strategy for mitigating the challenges of continuous cropping in pepper cultivation within the karst mountainous regions of Southwest China. Full article
Show Figures

Figure 1

Figure 1
<p>The effects of green manure return and biochar application on fresh (<b>A</b>) and dry (<b>B</b>) yield of continuous cropping pepper. Different lowercase letters indicate significant differences among different treatments at <span class="html-italic">p</span> &lt; 0.05 by the Duncan’s MRT method.</p>
Full article ">Figure 2
<p>The effects of green manure return and biochar application on yield stability (<b>A</b>) and sustainability (<b>C</b>) of fresh peppers, and yield stability (<b>B</b>) and sustainability (<b>D</b>) of dry peppers. Different lowercase letters indicate significant differences among different treatments at <span class="html-italic">p</span> &lt; 0.05 by the Duncan’s MRT method.</p>
Full article ">Figure 3
<p>The effects of green manure return and biochar application on N (<b>A</b>), P (<b>B</b>), and K (<b>C</b>) nutrient accumulation in 2021–2023. Different lowercase letters indicate significant differences among different treatments at <span class="html-italic">p</span> &lt; 0.05 by the Duncan’s MRT method.</p>
Full article ">Figure 4
<p>Effects of green manure return and biochar application on output value (<b>A</b>) and net income (<b>B</b>) of continuous cropping peppers in 2021–2023. Different lowercase letters indicate significant differences among different treatments at <span class="html-italic">p</span> &lt; 0.05 by the Duncan’s MRT method.</p>
Full article ">
19 pages, 8896 KiB  
Article
Estimation of Signal Distortion Bias Using Geometry-Free Linear Combinations
by Mohammed Abou Galala and Wu Chen
Remote Sens. 2024, 16(23), 4463; https://doi.org/10.3390/rs16234463 - 28 Nov 2024
Viewed by 426
Abstract
Signal distortion bias (SDB) in Global Navigation Satellite System (GNSS) data processing, defined as the time difference between the distorted chip and the ideal rectangular chip, leads to systematic biases in pseudoranges, affecting satellite and receiver differential code biases (DCBs). The stability of [...] Read more.
Signal distortion bias (SDB) in Global Navigation Satellite System (GNSS) data processing, defined as the time difference between the distorted chip and the ideal rectangular chip, leads to systematic biases in pseudoranges, affecting satellite and receiver differential code biases (DCBs). The stability of SDBs, allowing them to be treated as constant values, highlights the importance of investigating both their stability and estimation accuracy. Two different methods are used to estimate SDBs: (1) the hybrid method and (2) the geometry-free method. Data from approximately 430 stations, spanning the entire year of 2021, were analyzed to evaluate the estimation accuracy and the short-term and long-term stability of GPS SDBs. The analysis focused on two code signals: C1C (L1 Coarse/Acquisition) and C2W (L2 P(Y)). The results show that the short-term and long-term stability of GPS C1C and C2W SDBs is comparable for both methods, with only minor variations between them. Additionally, one month of data were used to validate the accuracy of estimated SDBs across different receiver groups. The results demonstrate that geometry-free SDBs provide stable satellite DCB estimates with an average bias below 0.15 ns and minimal residual biases, while hybrid SDBs provide satellite DCB estimates with an average bias below 0.20 ns. Overall, the comparison underscores the superior performance of geometry-free SDBs in achieving consistent satellite DCB estimates. Full article
(This article belongs to the Special Issue Multi-GNSS Precise Point Positioning (MGPPP))
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Distribution of the IGS stations on 31 January 2021.</p>
Full article ">Figure 2
<p>Number of receivers for different receiver groups in 2021.</p>
Full article ">Figure 3
<p>Distribution of firmware versions across stations in 2021.</p>
Full article ">Figure 4
<p>Flowchart of the source code for SDB estimation using the two methods: (<b>a</b>) the hybrid method and (<b>b</b>) the geometry-free method.</p>
Full article ">Figure 5
<p>SDB weekly means of GPS signal C1C for satellite G01 in 2021.</p>
Full article ">Figure 6
<p>SDB weekly means of GPS signal C2W for satellite G01 in 2021.</p>
Full article ">Figure 7
<p>Annual difference between estimated SDBs for the two methods: SDB C1C (cyan); SDB C2W (blue).</p>
Full article ">Figure 8
<p>Annual STDs of C1C SDBs for all receiver groups in 2021.</p>
Full article ">Figure 9
<p>Annual STDs of C2W SDBs for all receiver groups in 2021.</p>
Full article ">Figure 10
<p>Weekly STDs of C1C SDBs for all receiver groups in 2021.</p>
Full article ">Figure 11
<p>Weekly STDs of C2W SDB for all receiver groups in 2021.</p>
Full article ">Figure 12
<p>DCB estimates for GPS satellite G06 from 13 receiver groups, under three different scenarios: geometry-free SDBs, geometry-fixed/geometry-free SDBs, and no-correction SDBs.</p>
Full article ">Figure 13
<p>Mean bias in satellite DCBs for various receiver groups under the three different scenarios: geometry-free SDBs, geometry-fixed/geometry-free SDBs, and no correction.</p>
Full article ">Figure 14
<p>Distribution of biases in satellite DCB for two different scenarios: geometry-free SDBs and geometry-fixed/geometry-free SDBs.</p>
Full article ">
13 pages, 2298 KiB  
Article
Qualitative Transcriptional Signature for Predicting the Pathological Response of Colorectal Cancer to FOLFIRI Therapy
by Jun He, Mengyao Wang, Dandan Wu, Hao Fu and Xiaopei Shen
Int. J. Mol. Sci. 2024, 25(23), 12771; https://doi.org/10.3390/ijms252312771 - 27 Nov 2024
Viewed by 829
Abstract
FOLFIRI (5-FU, leucovorin, irinotecan) is the first-line chemotherapy for metastatic colorectal cancer (mCRC), but response rates are under 50%. This study aimed to develop a predictive signature for FOLFIRI response in mCRC patients. Firstly, Spearman’s rank correlation and Wilcoxon rank-sum test were used [...] Read more.
FOLFIRI (5-FU, leucovorin, irinotecan) is the first-line chemotherapy for metastatic colorectal cancer (mCRC), but response rates are under 50%. This study aimed to develop a predictive signature for FOLFIRI response in mCRC patients. Firstly, Spearman’s rank correlation and Wilcoxon rank-sum test were used to select chemotherapy response genes and gene pairs, respectively. Then, an optimization procedure was used to determine the final signature. A predictive signature consisting of three gene pairs (3-GPS) was identified. In the training set, 3-GPS achieved an accuracy of 0.94. In a validation set of 60 samples, predicted responders had significantly better progression-free survival than the predicted non-responders (HR = 0.47, p = 0.01). A comparable result was observed in an additional validation set of 27 samples (HR = 0.06, p = 0.02). The co-expressed genes of the signature were enriched in pathways associated with the immunotherapy response, and they interacted extensively with FOLFIRI-related genes. Notably, the expression of signature genes significantly correlated with various immune cell types, including plasma cells and memory-resting CD4+ T cells. In conclusion, the REO-based signature effectively identifies mCRC patients likely to benefit from FOLFIRI. Furthermore, these signature genes may play a crucial role in the chemotherapy. Full article
(This article belongs to the Topic Advances in Colorectal Cancer Therapy)
Show Figures

Figure 1

Figure 1
<p>Flowchart for the identification and validation of the relative expression ordering (REO)-based signature in the present study.</p>
Full article ">Figure 2
<p>Performance of 3-GPS signatures in identifying responder patients with FOLFIRI treatment. (<b>A</b>–<b>C</b>): The AUC in training datasets CRC47, CRC47-GSE72970, and CRC47-GSE62080.</p>
Full article ">Figure 3
<p>Univariate and multivariate Cox analysis for 3-GPS. (<b>A</b>–<b>C</b>): Univariate Cox analysis for 3-GPS in CRC60, CRC27, and the pooled datasets of CRC60 and CRC27. (<b>D</b>–<b>F</b>): Multivariate Cox analysis for 3-GPS in CRC60, CRC27, and the pooled datasets of CRC60 and CRC27 after adjusting for age, gender, stage, and tumor location. * <span class="html-italic">p</span>  &lt;  0.05. ** <span class="html-italic">p</span>  &lt;  0.01.</p>
Full article ">Figure 4
<p>The distribution of 3-GPS scores in different datasets. (<b>A</b>–<b>C</b>): The scores distribution in CRC47, CRC60, and CRC27.</p>
Full article ">Figure 5
<p>The function of genes in 3-GPS. (<b>A</b>–<b>E</b>) The enrichment result of co-expressed genes of <span class="html-italic">IKBKB-DT</span>, <span class="html-italic">OR7E14P</span>, <span class="html-italic">PLXNA4</span>, <span class="html-italic">RABGAP1,</span> and <span class="html-italic">CTSV</span>; (<b>F</b>) The co-expression network of genes in 3-GPS.</p>
Full article ">Figure 6
<p>Immune infiltration in mCRC. (<b>A</b>): Comparison of the ESTIMATE score, immune score, stromal score, and tumor purity levels between responder and non-responder mCRC. (<b>B</b>): Comparison of the 22 different kinds of immune cell types between responder and non-responder mCRC. (<b>C</b>): The correlation between the expression of signature genes and ESTIMATE score, immune score, and stromal score in mCRC. (<b>D</b>): The correlation between the expression of signature genes and 22 different kinds of immune cell types in mCRC. * <span class="html-italic">p</span>  &lt;  0.05, ns: no significant.</p>
Full article ">
18 pages, 4005 KiB  
Article
Discovery of Cyclic Peptide Inhibitors Targeted on TNFα-TNFR1 from Computational Design and Bioactivity Verification
by Jiangnan Zhang, Huijian Zhao, Qianqian Zhou, Xiaoyue Yang, Haoran Qi, Yongxing Zhao and Longhua Yang
Molecules 2024, 29(21), 5147; https://doi.org/10.3390/molecules29215147 - 31 Oct 2024
Viewed by 1415
Abstract
Activating tumor necrosis factor receptor 1 (TNFR1) with tumor necrosis factor alpha (TNFα) is one of the key pathological mechanisms resulting in the exacerbation of rheumatoid arthritis (RA) immune response. Despite various types of drugs being available for the treatment of RA, a [...] Read more.
Activating tumor necrosis factor receptor 1 (TNFR1) with tumor necrosis factor alpha (TNFα) is one of the key pathological mechanisms resulting in the exacerbation of rheumatoid arthritis (RA) immune response. Despite various types of drugs being available for the treatment of RA, a series of shortcomings still limits their application. Therefore, developing novel peptide drugs that target TNFα-TNFR1 interaction is expected to expand therapeutic drug options. In this study, the detailed interaction mechanism between TNFα and TNFR1 was elucidated, based on which, a series of linear peptides were initially designed. To overcome its large conformational flexibility, two different head-to-tail cyclization strategies were adopted by adding a proline-glycine (GP) or cysteine-cysteine (CC) to form an amide or disulfide bond between the N-C terminal. The results indicate that two cyclic peptides, R1_CC4 and α_CC8, exhibit the strongest binding free energies. α_CC8 was selected for further optimization using virtual mutations through in vitro activity and toxicity experiments due to its optimal biological activity. The L16R mutant was screened, and its binding affinity to TNFR1 was validated using ELISA assays. This study designed a novel cyclic peptide structure with potential anti-inflammatory properties, possibly bringing an additional choice for the treatment of RA in the future. Full article
(This article belongs to the Special Issue Recent Advances in Computer-Aided Drug Design and Drug Discovery)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>(<b>A</b>) The schematic diagram of the tertiary structure of TNFα, green and yellow represented the loop and β-sheet regions respectively. The lowercase letters in subfigure represent different β-sheets [<a href="#B9-molecules-29-05147" class="html-bibr">9</a>]. (<b>B</b>) The extracellular tertiary structure of TNFR1, cysteine, is represented by a yellow sphere. The four colors from top to bottom represent different regions of CRD1-4 (green, navy, purple, sky-blue). Both crystal structures were from the PDB bank (PDB ID: 7KPB [<a href="#B10-molecules-29-05147" class="html-bibr">10</a>,<a href="#B11-molecules-29-05147" class="html-bibr">11</a>]).</p>
Full article ">Figure 2
<p>(<b>A</b>) Initial model of TNFα-TNFR1 complex (PDB ID: 7KPB). The interaction interface is shown in red. (<b>B</b>,<b>C</b>) RMSD and RMSF of the TNFα-TNFR1 complex (black) and the binding interface (red).</p>
Full article ">Figure 3
<p>Per-residue free energy decomposition diagrams for TNFR1 (<b>A</b>) and TNFα (<b>B</b>). The residues with energy less than −1 kcal·mol<sup>−1</sup> were plotted, and different energy terms are shown with different colors. (<b>C</b>) Hydrogen bond formed between Arg68 and Glu127.</p>
Full article ">Figure 4
<p>Binding free energy changes after mutations (within 5 Å of binding interface). (<b>A</b>) TNFR1; (<b>B</b>) TNFα. Hot-spot residues contributing −2 kcal·mol<sup>−1</sup> are filled in red. (<b>C</b>) Interaction with Leu75 before and after Trp107 mutation. The blue and yellow ribbons represent TNFR1 and TNFα, respectively. X represents the interaction disappeared after mutation.</p>
Full article ">Figure 5
<p>Binding sites schematic diagram of TNFR1 (<b>A</b>) and TNFα (<b>B</b>). The CRD1–4 regions of TNFR1 were represented from top to bottom.</p>
Full article ">Figure 6
<p>(<b>A</b>) Primary sequence and (<b>B</b>) topology of the CRD2 region in TNFR1.The green line represents the disulfide bond formed between two cysteines.</p>
Full article ">Figure 7
<p>RMSD of different cyclic peptide-protein complexes. (<b>A</b>) RMSD of R1_GPX-TNFα complexes; (<b>B</b>) RMSD of R1_CCX-TNFα complexes; (<b>C</b>) RMSD of α_GPX-TNFR1 complexes; (<b>D</b>) RMSD of α_CCX-TNFR1 complexes.</p>
Full article ">Figure 8
<p>Cell toxicity of the different concentrations of cyclic peptides (<b>A</b>) cyclic peptide R1_CC4. (<b>B</b>) cyclic peptide α_CC8. Data represented as mean ± SEM (<span class="html-italic">n</span> = 3).</p>
Full article ">Figure 9
<p>Survival rate of L929 cells in presence of 1 μg/mL Etanercept (EN positive control) and different concentrations of cyclic peptides. (<b>A</b>) cyclic peptide R1_CC4. (<b>B</b>) cyclic peptide α_CC8. Data are representative of three replicates. Data represented as mean ± SEM (<span class="html-italic">n</span> = 3). (* <span class="html-italic">p</span> &lt; 0.05 and ** <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 10
<p>The virtual mutation flow chart of α_CC8.The red highlighted font represents the abbreviation of the amino acid to be mutated, the red arrow indicates the specific mutation process, and the red font at the bottom is the final screening result after mutation.</p>
Full article ">Figure 11
<p>Binding affinities of L16R and WP9QY (positive control) toward the hTNF1, as determined by ELISA. (<b>A</b>) Absorbance values of L16R and WP9QY at different concentrations; (<b>B</b>) Binding affinity curves of cyclic peptide L16R and WP9QY. Data represented as mean ± SEM (<span class="html-italic">n</span> = 3).</p>
Full article ">
25 pages, 29809 KiB  
Article
A Vision-Based End-to-End Reinforcement Learning Framework for Drone Target Tracking
by Xun Zhao, Xinjian Huang, Jianheng Cheng, Zhendong Xia and Zhiheng Tu
Drones 2024, 8(11), 628; https://doi.org/10.3390/drones8110628 - 30 Oct 2024
Viewed by 1519
Abstract
Drone target tracking, which involves instructing drone movement to follow a moving target, encounters several challenges: (1) traditional methods need accurate state estimation of both the drone and target; (2) conventional Proportional–Derivative (PD) controllers require tedious parameter tuning and struggle with nonlinear properties; [...] Read more.
Drone target tracking, which involves instructing drone movement to follow a moving target, encounters several challenges: (1) traditional methods need accurate state estimation of both the drone and target; (2) conventional Proportional–Derivative (PD) controllers require tedious parameter tuning and struggle with nonlinear properties; and (3) reinforcement learning methods, though promising, rely on the drone’s self-state estimation, adding complexity and computational load and reducing reliability. To address these challenges, this study proposes an innovative model-free end-to-end reinforcement learning framework, the VTD3 (Vision-Based Twin Delayed Deep Deterministic Policy Gradient), for drone target tracking tasks. This framework focuses on controlling the drone to follow a moving target while maintaining a specific distance. VTD3 is a pure vision-based tracking algorithm which integrates the YOLOv8 detector, the BoT-SORT tracking algorithm, and the Twin Delayed Deep Deterministic Policy Gradient (TD3) algorithm. It diminishes reliance on GPS and other sensors while simultaneously enhancing the tracking capability for complex target motion trajectories. In a simulated environment, we assess the tracking performance of VTD3 across four complex target motion trajectories (triangular, square, sawtooth, and square wave, including scenarios with occlusions). The experimental results indicate that our proposed VTD3 reinforcement learning algorithm substantially outperforms conventional PD controllers in drone target tracking applications. Across various target trajectories, the VTD3 algorithm demonstrates a significant reduction in average tracking errors along the X-axis and Y-axis of up to 34.35% and 45.36%, respectively. Additionally, it achieves a notable improvement of up to 66.10% in altitude control precision. In terms of motion smoothness, the VTD3 algorithm markedly enhances performance metrics, with improvements of up to 37.70% in jitter and 60.64% in Jerk RMS. Empirical results verify the superiority and feasibility of our proposed VTD3 framework for drone target tracking. Full article
Show Figures

Figure 1

Figure 1
<p>Framework of the <tt>VTD3</tt> for drone target tracking.</p>
Full article ">Figure 2
<p>YOLOv 8 network architecture.</p>
Full article ">Figure 3
<p>Workflow of the BoT-SORT tracker.</p>
Full article ">Figure 4
<p>TD3 network training framework.</p>
Full article ">Figure 5
<p>Actor and Q network structures.</p>
Full article ">Figure 6
<p>Simulation process diagram.</p>
Full article ">Figure 7
<p>Demonstration of various target occlusion scenarios encountered in drone tracking. The scenarios include the following: Unoccluded, where the entire target is visible; Front Occluded, where the front portion of the target is obscured; and Rear Occluded, where the rear part of the target is hidden from view. These scenarios exemplify typical challenges faced in practical drone tracking applications.</p>
Full article ">Figure 8
<p>Training results of YOLOv8. The blue curves represent the values of each metric for each epoch, while the orange curves show the smoothed results.</p>
Full article ">Figure 9
<p>Detection results for YOLOv8.</p>
Full article ">Figure 10
<p>Training rewards over episodes for the TD3 network. The graph shows the total reward per episode (blue) and the moving average reward (orange) throughout the training process. The x-axis represents the number of episodes, while the y-axis indicates the reward value for each episode. The training process is divided into three stages: the random exploration stage (episodes 0–1000), noisy exploration stage (episodes 1000–1500), and pure policy stage (episodes 1500–2000). These stages are demarcated by green dashed lines on the graph. The progression of rewards illustrates the learning performance of the TD3 network across different exploration strategies.</p>
Full article ">Figure 11
<p>Four distinct vehicle motion trajectories are implemented in our experiments: triangular, square, sawtooth, and square wave. The X- and Y-axis in each figure represent the horizontal and vertical coordinates, respectively, measured in meters. The red lines depict the vehicle’s movement path. Notably, the square wave trajectory includes three gray boxes representing scenarios where the vehicle is occluded.</p>
Full article ">Figure 12
<p>Drone tracking performance under four vehicle trajectory patterns (triangular, square, sawtooth, and square wave). Each row presents five plots: X and Y position over time (columns 1–2), altitude (Z) over time (column 3), and X and Y velocity over time (columns 4–5). The red curve represents the vehicle, the blue curve represents the TD3 controller, and the green curve represents the PD controller. The y-axis units for the first three columns are in meters (m), while the last two columns use meters per second (m/s). The x-axis unit for all plots is seconds (s).</p>
Full article ">Figure 13
<p>Performance comparison of PD and TD3 controllers in triangular trajectory tracking.</p>
Full article ">Figure 14
<p>Performance comparison of PD and TD3 controllers in square trajectory tracking.</p>
Full article ">Figure 15
<p>Performance comparison of PD and TD3 controllers in sawtooth trajectory tracking.</p>
Full article ">Figure 16
<p>Performance comparison of PD and TD3 controllers in square wave trajectory tracking.</p>
Full article ">
16 pages, 5103 KiB  
Article
Rural Poultry Farming: Leveraging Higher Poultry Input Costs to Grow Zambia’s Indigenous Chicken Sector
by Christopher Manchishi Kanyama, Mathews Ngosa, Terence Z. Sibanda, Amy F. Moss and Tamsyn M. Crowley
Poultry 2024, 3(4), 383-398; https://doi.org/10.3390/poultry3040029 - 29 Oct 2024
Viewed by 1600
Abstract
(a) Introduction: Zambia’s poultry industry comprises commercial chickens and small-scale producers of indigenous chickens (Gallus domesticus) (ICs). Large, integrated entities run the commercial chicken sector, while the indigenous chicken sector (IC sector) is predominantly run by small-scale farmers (SSFs). Increased costs [...] Read more.
(a) Introduction: Zambia’s poultry industry comprises commercial chickens and small-scale producers of indigenous chickens (Gallus domesticus) (ICs). Large, integrated entities run the commercial chicken sector, while the indigenous chicken sector (IC sector) is predominantly run by small-scale farmers (SSFs). Increased costs and low access to formal markets for commercial chickens have motivated SSFs to enter the IC sector under the free-range system (FRS) and semi-intensive system (SIS). (b) Objective: This study aimed to highlight the price changes in poultry inputs and outputs and demonstrate that the IC sector has more potential to contribute to farm income than commercial chickens under family poultry production systems. (c) Method: We analysed the prices for inputs and outputs for Zambia’s poultry industry for the first quarter of 2016 to 2023 using data from the Poultry Association of Zambia (PAZ). We also analysed data from the 2021 Qualtrics survey to investigate the crops grown and crops used as feed and feed ingredients, the sources of feed, and the use of minerals and vitamins by SSFs for chickens. The gross profit (GP) and benefit–cost ratio (BCR) were analysed to compare the viability and profitability of ICs and broilers under SSFs. (d) Results: Our study shows that prices for day-old chicks (DOCs) and point-of-lay (POL) pullets increased by 57–125%, broiler and layer feeds increased by 67–96%, and soybean meal (SBM) and fishmeal rose by 143–229%. Prices for live ICs, commercial broilers, and ex-layers increased by 150%, 79%, and 71%, respectively. Egg prices rose by 100–124%. Farmers tried to look for local feed sources. Over 21% of the crops grown was maize, and nearly 43% was used for feed. (e) Conclusion: Our analysis and comparison between the ICs and broilers demonstrated that SSFs could achieve more farm income by producing ICs than commercial broilers. Full article
Show Figures

Figure 1

Figure 1
<p>(<b>a</b>) Broilers under small-scale intensive system; and (<b>b</b>) rearing indigenous chickens under the free-range system; images source: authors.</p>
Full article ">Figure 2
<p>Price trend for live inputs: (<b>a</b>) broiler and layer DOCs; and (<b>b</b>) POL pullets. Note: the average exchange rate was USD 1 = ZMW 14.45, DOCs = day-old-chicks, POL = point-of-lay.</p>
Full article ">Figure 3
<p>Price trend for selected feed ingredients—SBM and fishmeal. Note: the average exchange rate was USD 1= ZMW 14.45, SBM = soybean meal.</p>
Full article ">Figure 4
<p>Price trends for poultry feeds: (<b>a</b>) broiler starter, grower, and finisher; and (<b>b</b>) layer starter, grower, developer, and mash. Note: the average exchange rate was USD 1 = ZMW 14.45.</p>
Full article ">Figure 5
<p>Price trend for chickens and products: (<b>a</b>) ICs, broilers, and ex-layers; and (<b>b</b>) farm gate and national retail prices for a tray of 30 eggs. Note: the average exchange rate was USD 1 = ZMW 14.45, ICs = indigenous chickens.</p>
Full article ">Figure 6
<p>Sources of poultry feed. Note: N = number of respondents in the: (<b>i</b>) eastern (N = 158); (<b>ii</b>) central (N = 100); (<b>iii</b>) southern livelihood zones (N = 100); and (<b>iv</b>) overall (N = 358). Other sources were unspecified.</p>
Full article ">Figure 7
<p>Common field crops: (<b>a</b>) that farmers grow; and (<b>b</b>) crops or by-products farmers use as chicken feed supplements. Note: N = number of respondents = 358. Other crops included watermelons, velvet beans, tomatoes, tobacco, onion, cowpeas, sun hemp, kidney beans, cotton, and popcorn.</p>
Full article ">Figure 8
<p>Proportion of farmers’ responses when asked if they used vitamins and minerals in poultry production. Note: N = number of respondents in the: (<b>i</b>) eastern (N = 158); (<b>ii</b>) central (N = 100); (<b>iii</b>) southern livelihood zones (N = 100); and (<b>iv</b>) overall (N = 358).</p>
Full article ">
14 pages, 2455 KiB  
Article
Cement-Free Geopolymer Paste: An Eco-Friendly Adhesive Agent for Concrete and Masonry Repairs
by Tayseer Z. Batran, Mohamed K. Ismail, Mohamed I. Serag and Ahmed M. Ragab
Buildings 2024, 14(11), 3426; https://doi.org/10.3390/buildings14113426 - 28 Oct 2024
Viewed by 998
Abstract
This study aimed to investigate the feasibility of using geopolymer paste (GP) as an adhesive agent for (i) anchoring steel bars in concrete substrates, (ii) repairing concrete, and (iii) repairing limestone and granite masonry blocks commonly found in historic buildings. In this investigation, [...] Read more.
This study aimed to investigate the feasibility of using geopolymer paste (GP) as an adhesive agent for (i) anchoring steel bars in concrete substrates, (ii) repairing concrete, and (iii) repairing limestone and granite masonry blocks commonly found in historic buildings. In this investigation, seven cement-free GP mixes were developed with different combinations of binder materials (slag, silica fume, and metakaolin). The mechanical properties, adhesive performance, and production cost of the developed GP mixes were compared to those of a commercially epoxy adhesive mortar (EAM). The results obtained from this study indicated that the use of GPs enhanced the bonding between steel bars and concrete substrates, achieving bonding strengths that were 19.7% to 49.2% higher than those of control specimens with steel bars directly installed during casting. In concrete repairs, the GPs were able to restore about 60.6% to 87.9% of the original capacity of the control beams. Furthermore, GPs exhibited a promising performance in repairing limestone and granite masonry blocks, highlighting their potential suitability for masonry structures. The best adhesive performance was observed when a ternary binder material system consisting of 70% slag, 20% metakaolin and 10% silica fume was used. This combination, compared to the investigated EAM, showed comparable adhesive properties at a significantly low cost, indicating the viability of GPs as a cost-effective, eco-friendly adhesive agent. Full article
(This article belongs to the Section Building Materials, and Repair & Renovation)
Show Figures

Figure 1

Figure 1
<p>Test setup and specimens’ geometry.</p>
Full article ">Figure 2
<p>Compressive strength and STS of all developed GP mixes.</p>
Full article ">Figure 3
<p>Pull-out strengths.</p>
Full article ">Figure 4
<p>Flexural test results of the control and repaired beams.</p>
Full article ">Figure 5
<p>Typical failure patterns of tested beams.</p>
Full article ">Figure 6
<p>Flexural test results of the granite and limestone specimens.</p>
Full article ">Figure 7
<p>Typical failure patterns of tested limestone and granite specimens.</p>
Full article ">
Back to TopTop